Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Centessa Pharmaceuticals Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesJun 21 22:25

Morgan Stanley Adjusts Price Target on Centessa Pharmaceuticals to $11 From $8, Maintains Equalweight Rating

Centessa Pharmaceuticals (CNTA) has an average buy rating and price target range of $11 to $20, according to analysts polled by Capital IQ. Price: 9.14, Change: +0.28, Percent Change: +3.10

MT NewswiresJun 21 22:21

Centessa Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 11.56% Morgan Stanley $8 → $11 Maintains Equal-Weight 04/01/2024 52.13% BMO Capital $15 → $15 M

BenzingaJun 21 22:13

Express News | Centessa Pharmaceuticals, Inc : Morgan Stanley Raises Target Price to $11.00 From $8.00

BreakingsJun 21 20:44

Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Hold Rating, Raises Target Price to $11

Morgan Stanley analyst Jeffrey Hung maintains $Centessa Pharmaceuticals(CNTA.US)$ with a hold rating, and adjusts the target price from $8 to $11.According to TipRanks data, the analyst has a success

Futu NewsJun 21 20:31 · Ratings

Centessa Pharmaceuticals Plc's (NASDAQ:CNTA) Institutional Investors Lost 12% Over the Past Week but Have Profited From Longer-term Gains

Key Insights Significantly high institutional ownership implies Centessa Pharmaceuticals' stock price is sensitive to their trading actions A total of 8 investors have a majority stake in the compan

Simply Wall StJun 20 23:59